Cargando…

Therapeutic Drug Monitoring of Antimicrobials in Critically Ill Obese Patients

Obesity is a significant global public health concern that is associated with an elevated risk of comorbidities as well as severe postoperative and nosocomial infections. The treatment of infections in critically ill obese patients can be challenging because obesity affects the pharmacokinetics and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gorham, Julie, Taccone, Fabio S., Hites, Maya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376599/ https://www.ncbi.nlm.nih.gov/pubmed/37508195 http://dx.doi.org/10.3390/antibiotics12071099

Ejemplares similares

Drug Regimens of Novel Antibiotics in Critically Ill Patients with Varying Renal Functions: A Rapid Review
por: Gorham, Julie, et al.
Publicado: (2022)

How to Use Nebulized Antibiotics in Severe Respiratory Infections
por: Gorham, Julie, et al.
Publicado: (2023)

Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base
por: Taccone, Fabio S, et al.
Publicado: (2020)

Broad-spectrum β-lactams in obese non-critically ill patients
por: Hites, M, et al.
Publicado: (2014)

A Retrospective, Monocentric Study Comparing Co and Secondary Infections in Critically Ill COVID-19 and Influenza Patients
por: Marcoux, Diane, et al.
Publicado: (2022)

Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper(#)
por: Abdul-Aziz, Mohd H., et al.
Publicado: (2020)

The obesity paradox for survivors of critically ill patients
por: Zhou, Dawei, et al.
Publicado: (2022)

From hydroxychloroquine to ivermectin: how unproven “cures” can go viral
por: Taccone, Fabio Silvio, et al.
Publicado: (2022)

Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis
por: Gorham, Julie, et al.
Publicado: (2020)

Simultaneous Quantification of Nine Antimicrobials by LC-MS/MS for Therapeutic Drug Monitoring in Critically Ill Patients
por: Neugebauer, Sophie, et al.
Publicado: (2019)

Prediction of Insufficient Beta-Lactam Concentrations in Extracorporeal Membranous Oxygenation Patients
por: Polain, Amandine, et al.
Publicado: (2021)

Therapeutic Drug Monitoring in Arterial Hypertension
por: Seleznev, Sergey, et al.
Publicado: (2023)

Continuous infusion of meropenem in critically ill patients: practical considerations
por: Taccone, Fabio Silvio
Publicado: (2012)

Therapeutic drug monitoring of amikacin in septic patients
por: Duszynska, Wieslawa, et al.
Publicado: (2013)

Is There a Role for the Therapeutic Drug Monitoring of Colistin? An Overview
por: Avila, Maria-Paula, et al.
Publicado: (2020)

Circulating Gasdermin-D in Critically Ill Patients
por: Homsy, Elie, et al.
Publicado: (2019)

Unexpected Interruptions in the Inhaled Epoprostenol Delivery System: Incidence of Adverse Sequelae and Therapeutic Consequences in Critically Ill Patients
por: Block, Jason M., et al.
Publicado: (2021)

Therapeutic Drug Monitoring of Isavuconazole—But What about the Critically Ill?
por: Salhotra, Ripenmeet
Publicado: (2023)

B-lactams serum concentrations in critically ill cirrhotic patients: a matched-control study
por: Lheureux, O, et al.
Publicado: (2015)

Penetration of Isavuconazole in Ascites Fluid of Critically Ill Patients
por: Lahmer, Tobias, et al.
Publicado: (2021)

Therapeutic plasma exchange in the intensive care unit and with the critically ill, a focus on clinical nursing considerations
por: Baldwin, Ian, et al.
Publicado: (2022)

Clinical sepsis phenotypes in critically ill COVID-19 patients
por: Bruse, Niklas, et al.
Publicado: (2022)

Optimizing Antimicrobial Drug Dosing in Critically Ill Patients
por: Póvoa, Pedro, et al.
Publicado: (2021)

Haemodynamic monitoring in critically ill patients
por: Rhodes, Andrew, et al.
Publicado: (2004)

Extensive Therapeutic Drug Monitoring of Colistin in Critically Ill Patients Reveals Undetected Risks
por: Ehrentraut, Stefan Felix, et al.
Publicado: (2020)

Evaluation of Real-World Vancomycin Dosing and Attainment of Therapeutic Drug Monitoring Targets
por: Bradley, Nicole, et al.
Publicado: (2023)

Peripheral Inotropes in Critically Ill Children: Is It Safe?
por: Mooli, Ravi K., et al.
Publicado: (2021)

Pulse Oximetry and Race in Critically Ill Adults
por: Seitz, Kevin P., et al.
Publicado: (2022)

Secondary Bacterial Infections in Critical Ill Patients With Coronavirus Disease 2019
por: Fu, Yiqi, et al.
Publicado: (2020)

The Acquisition of Multidrug-Resistant Bacteria in Patients Admitted to COVID-19 Intensive Care Units: A Monocentric Retrospective Case Control Study
por: Bogossian, Elisa G., et al.
Publicado: (2020)

Therapeutic drug monitoring of vancomycin in an obese patient with renal insufficiency
por: Abuhasna, Said, et al.
Publicado: (2011)

Rotational thromboelastometry in critically ill COVID‐19 patients does not predict thrombosis
por: Dujardin, Romein W. G., et al.
Publicado: (2022)

Is Tocilizumab Plus Dexamethasone Associated with Superinfection in Critically Ill COVID-19 Patients?
por: Camou, Fabrice, et al.
Publicado: (2022)

Serum biomarkers identify critically ill traumatic brain injury patients for MRI
por: Richter, Sophie, et al.
Publicado: (2022)

Is non-thyroidal illness syndrome (NTIS) a clinical predictor of COVID-19 mortality in critically ill oldest old patients?
por: Okoye, C., et al.
Publicado: (2022)

The Current Status and Future Perspectives of Beta-Lactam Therapeutic Drug Monitoring in Critically Ill Patients
por: Novy, Emmanuel, et al.
Publicado: (2023)

Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?
por: Baracaldo-Santamaría, Daniela, et al.
Publicado: (2022)

Therapeutic monitoring of amikacin and gentamicin in critically and noncritically ill patients
por: Kovačević, Tijana, et al.
Publicado: (2016)

Efficacy of Fosfomycin-Containing Regimens for Treatment of Bacteremia Due to Pan-Drug Resistant Acinetobacter baumannii in Critically Ill Patients: A Case Series Study
por: Assimakopoulos, Stelios F., et al.
Publicado: (2023)

318. Beta-lactam Therapeutic Drug Monitoring Improves Attainment of Target Drug Levels in Critically Ill Patients
por: Ausman, Sara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dmd4890bocvflaed19noid839f